A recombinant human GLP-1 receptor dependent pathways coupled with saciety, gastrointestinal motility, and glucose homeostasis
If global access to effective anti-obesity pharmacotherapy expanded dramatically over the next 2 years, a plausible scenario given manufacturing scale-up and policy prioritisation, a synchronised reduction in adipose mass could occur across hundreds of millions to billions of individuals
Schumer has a financial stake in a startup that reached a $150 million revenue run rate as of October 2025
Chytridiomycosis was first described in the 1990s, during a precipitous decline in frog populations
It does plausibly explain diabetes risk, Soto-Mota said
First, the arginine salt may alter the solubility and stability of the solid formulation